These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1036622)

  • 1. The increased release of 3H-5-hydroxytryptamine by d-para-methoxyamphetamine and d-amphetamine in vivo.
    Tseng LF
    Proc West Pharmacol Soc; 1976; 19():136-41. PubMed ID: 1036622
    [No Abstract]   [Full Text] [Related]  

  • 2. 4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats.
    Hegadoren KM; Greenshaw AJ; Baker GB; Martin-Iverson MT; Lodge B; Soin S
    J Psychiatry Neurosci; 1994 Jan; 19(1):57-62. PubMed ID: 8148367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of d-amphetamine and potassium on serotonin release and metabolism in rat cerebral cortex tissue.
    Homan HD; Ziance RJ
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):223-40. PubMed ID: 6164082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of para-methoxyamphetamine induced serotonin release by serotonin uptake inhibitors.
    Tseng LF
    Proc West Pharmacol Soc; 1978; 21():7-9. PubMed ID: 308662
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological evidence for the central serotonergic effects of monomethoxyamphetamines.
    Menon MK; Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):272-9. PubMed ID: 946817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
    Tseng LF; Menon MK; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of para-methoxyamphetamine- induced serotonergic effects by chlorimipramine.
    Tseng LF; Harris RA; Loh NH
    J Pharmacol Exp Ther; 1978 Jan; 204(1):27-38. PubMed ID: 579354
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative potency of amphetamine isomers in causing the serotonin behavioral syndrome in rats.
    Sloviter RS; Damiano BP; Connor JD
    Biol Psychiatry; 1980 Oct; 15(5):789-96. PubMed ID: 7417631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of barbital and disulfiram on the metabolism of intracerebroventricularly administered [14C]-5-hydroxytryptamine in rats.
    Fukumori R; Minegishi A; Satoh T; Kitagawa H; Yanaura S
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):217-20. PubMed ID: 515504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)-amphetamine, p-methoxyamphetamine and harmaline.
    Green AL; El Hait MA
    Biochem Pharmacol; 1980 Oct; 29(20):2781-9. PubMed ID: 6893669
    [No Abstract]   [Full Text] [Related]  

  • 13. Analgesic and behavioral effects of amphetamine enantiomers, p-methoxyamphetamine and n-alkyl-p-methoxyamphetamine derivatives.
    Bustamante D; Díaz-Véliz G; Paeile C; Zapata-Torres G; Cassels BK
    Pharmacol Biochem Behav; 2004 Oct; 79(2):199-212. PubMed ID: 15501295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of alphaMT on anorectic and stimulatory action of amphetamines.
    Cox RH; Maickel RP
    Res Commun Chem Pathol Pharmacol; 1975 Dec; 12(4):621-6. PubMed ID: 1215654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-tyrosine on brain monoamines in rats given intravenous amphetamine.
    Smith DG; Geis LS; Lyness WH
    Subst Alcohol Actions Misuse; 1984-1985; 5(6):293-8. PubMed ID: 6085821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine.
    Kaminskas LM; Irvine RJ; Callaghan PD; White JM; Kirkbride P
    Psychopharmacology (Berl); 2002 Mar; 160(2):155-60. PubMed ID: 11875633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central action of 6-hydroxytryptamine in rats.
    Jamrozik-Kruk Z; Brus R
    Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol.
    Quintanilla ME; Bustamante D; Tampier L; Israel Y; Herrera-Marschitz M
    Eur J Pharmacol; 2007 Nov; 573(1-3):84-92. PubMed ID: 17651729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of p-chloroamphetamine and 1-(p-chlorophenyl)piperazine on 5-hydroxyindole concentration in rat brain.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):201-4. PubMed ID: 6157183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of amphetamine and its metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine, on uptake, release and catabolism of 3H-norepinephrine in cerebral cortex of rat brain.
    Wenger GR; Rutledge CO
    J Pharmacol Exp Ther; 1974 Jun; 189(3):725-32. PubMed ID: 4152317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.